Eurofins DiscoverX expands program with Catalent
June 29, 2020 -- Eurofins DiscoverX has expanded its contract research organization certification program for bioassays with Catalent Biologics as the North American provider.
Consortium studies body-on-a-chip technology
June 26, 2020 -- The Wake Forest Institute for Regenerative Medicine and Oracle Health Sciences have joined forces to develop a consortium of industry, government, and academic members to study novel approaches to establish drug safety.
Celltex moves COVID-19 prophylactic to clinical trials
June 26, 2020 -- Celltex has received approval from the U.S. Food and Drug Administration to investigate the prophylactic efficacy of autologous adipose tissue-derived mesenchymal stem cells against COVID-19.
Entos to begin phase I/II study of COVID-19 vaccine candidate
June 26, 2020 -- Entos Pharmaceuticals has selected two lead candidates for a pancoronavirus Fusogenix DNA vaccine (Covigenix) from its prototyping program to initiate phase I/II human clinical trials in late July.
Catalent to provide fill-finish for Moderna's COVID-19 vaccine
June 25, 2020 -- Catalent will collaborate with Moderna for large-scale commercial fill-finish manufacturing of Moderna's messenger RNA-based COVID-19 vaccine candidate, mRNA-1273, at Catalent's biologics facility in Bloomington, IN.
CEPI ramps up manufacturing for COVID-19 vaccines
June 25, 2020 -- The Coalition for Epidemic Preparedness Innovations (CEPI) signed an agreement with Italy-based Stevanto Group for the supply of 100 million glass vials to hold up to 2 billion doses of a COVID-19 vaccine.
MaxCyte launches Expert cell engineering products
June 25, 2020 -- Cell-based medicines and life sciences company MaxCyte has launched a new line of disposable cell engineering products.
ReNeuron to manufacture exosomes for gene therapies
June 25, 2020 -- ReNeuron signed a research evaluation agreement with a U.S. biotechnology company for the use of its proprietary exosomes for the delivery of novel gene silencing therapies.
Halo Labs launches protein identification instrument
June 25, 2020 -- Life science instrumentation company Halo Labs has launched Aura, an aggregate and particle identification system.
C-Path launches drug repurposing platform
June 24, 2020 -- Critical Path Institute (C-Path) has launched a drug repurposing platform to accelerate the identification of new uses of existing drugs to treat infections, including COVID-19.
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter